1.Comparison of the physicochemical and pharmacopeial properties of starches obtained from Artocarpus odoratissimus Blanco, Nephelium lappaceum L., and Mangifera indica L. seeds with corn starch.
Erna C. AROLLADO ; Joriza Mae M. PELLAZAR ; Richelle Ann M. MANALO ; Mae Pauline F. SIOCSON ; Romeo-Luis F. RAMIREZ
Acta Medica Philippina 2018;52(4):360-365
BACKGROUND: This study was conducted to characterize and compare the physicochemical and pharmacopoeial properties of starches isolated from the seeds of Artocarpus odoratissimus Blanco (marang), Nephelium lappaceum L. (rambutan), and unripe green Mangifera indica L. (mango) with corn starch, as possible sources of pharmaceutical grade starch.
METHODS: The starch from the seeds of these fruits was isolated and characterized through their physicochemical (organoleptic characteristics, percent yield, amylose-amylopectin ratio, bulk density, tapped density, compressibility index, Hausner ratio, angle of repose, solubility, swelling power, and viscosity) and pharmacopoeial properties (identification test, pH, loss on drying, and limit of iron). Morphology of the granules was also assessed.
RESULTS: The physicochemical properties showed that amylose content of the seed starches was significantly lower (p=0.001) and amylopectin content significantly higher (p=0.001) than the native high amylose corn starch. The lower values of bulk and tapped densities, and high values in compressibility index and Hausner ratio of the seed starches compared to corn starch may be due to their smaller particles. The results of the pharmacopoeial characterization showed compliance with the United States Pharmacopeia's (USP) acceptable limits, except for the pH of marang seeds.
CONCLUSION: The starches isolated from the fruit seeds have unique properties, but only rambutan seed starch has the most desirable physicochemical and pharmacopoeial properties that is comparable with corn starch. Rambutan seeds could be utilized as a source of starch for pharmaceutical applications.
Plant ; Mangifera ; Seeds ; Starch
2.Ethanolic extract of Garcinia mangostana L. pericarp as preservative in antacid suspension
Richelle Ann M. Manalo ; Erna C. Arollado ; Irizh-Lyn R. Sampang ; Janvin Jessel A. Cariscal ; Gerwin Louis T. Dela Torre
Acta Medica Philippina 2018;52(4):349-355
Objective:
The study was conducted to determine the preservative activity of ethanolic extract of mangosteen (Garcinia mangostana L.) pericarp and its compatibility in an antacid suspension.
Methods:
The extract was subjected to phytochemical screening and was used as preservative in a formulated antacid suspension. Compatibility with the active pharmaceutical ingredient (API) and excipients were analyzed using fourier transform-infrared spectroscopy. Preservative activity of the formulation against Escherichia coli, Staphylococcus aureus, and Pseudomonas aeruginosa was assessed using the United States Pharmacopoeia (USP) antimicrobial effectiveness test, with methylparaben as positive control and suspension without preservative as negative control.
Results:
The extract exhibited pharmaceutical compatibility with API and excipients. The formulation revealed comparable reduction in microbial count of E. coli, S. aureus, and P. aeruginosa with positive control at Day 14 (p=0.916, 0.624, 0.335). At Day 28, comparable activity with positive control was only observed against E. coli and S. aureus (p=0.999, 0.854). However, it displayed significant increase in activity against P. aeruginosa (p=0.010) at Day 28. These activities may be attributed to glycosides and reducing substances present in the extract.
Conclusion
The ethanolic extract from Garcinia mangostana L. pericarp acted as a preservative in the formulation of an antacid suspension. It conformed to the USP criteria for antimicrobial effectiveness test on bacteria.
Garcinia mangostana
;
Suspensions
3.Optimization of the isolation and purification method of pharmaceutical grade pectin from pomelo fruit peels (Citrus maxima Merr. Family Rutaceae).
Erna C. AROLLADO ; Romeo-Luis F. RAMIREZ ; Richelle Ann M. MANALO ; Gerwin Louis T. DELA TORRE ; Kerstin Mariae G. PONSARAN ; Shaina Mara M. SALVADOR ; Mae Pauline F. SIOCSON
Acta Medica Philippina 2018;52(4):356-359
BACKGROUND: Pectin is a heteropolysaccharide used in pharmaceutical formulations as a binding agent. Importation of pectin costs billions of Philippine pesos, but the local laboratory-scale production of this excipient from fruit peel wastes is estimated to be cheaper by 80%.
OBJECTIVE: To address economic and environment concerns associated with pectin production, this study aimed to optimize the isolation and purification of pharmaceutical grade pectin from pomelo (Citrus maxima Merr.) fruit peel as basis for commercial-scale production.
METHODS: Pectin was extracted from pomelo using different solvents: 6.2% w/w citric acid, 1N acetic acid, 3N hydrochloric acid, 3N nitric acid, and 3N sulfuric acid. Temperatures for extracting pectin were explored at 40°C, 60°C, and 90°C. Obtained pectin samples were characterized based on the following parameters: equivalent weight (EW), methoxyl content (MC), ash content (AC), anhydrouronic acid content (AUA), and degree of esterification (DE).
RESULTS: Highest pectin yield (9.25%) was obtained using 3N nitric acid and 3N sulfuric acid at 90°C.Based from the pharmacopeial standards (MC ? 6.7, AUA ? 74.0), all the samples did not pass the parameters, except the pectin extracted using 3N sulfuric acid at 90°C (MC = 6.76, AUA = 74.61).
CONCLUSION: Among the different solvents used for extraction, 3N sulfuric acid produced the highest percent yield of pharmaceutical grade pectin from pomelo fruit peel. Its optimum temperature for extraction was at 90°C. The sample passed the USP standards of MC values not less than 6.76 and AUA values not less than 74. Under the following conditions, pomelo fruit peel have the potential for commercial-scale production of pharmaceutical grade pectin.
Plant ; Citrus
4.Molecular biomarkers detected using fluorescence in situ hybridizationin a Filipino with retinoblastoma
Arnold Dominic A. Barzaga ; Glenmarie Angelica S. Perias ; Lia Angela E. Reyes ; Patrick Gabriel G. Moreno ; Patrick R. Relacion ; Richelle Ann M. Manalo ; Yasmyne C. Ronquillo ; Francisco M. Heralde III
Acta Medica Philippina 2024;58(10):99-107
Background and Objective:
Retinoblastoma is one of the most common intraocular cancers among children usually caused by the loss of retinoblastoma protein function. Despite being a highly heritable disease, conventional diagnostic and prognostic methods depend on clinical examination, with limited consideration of cancer genetics in the standard of care. CD133, KRT19, and MUC1 are commonly explored genes for their utility in liquid biopsies of cancer including lung adenocarcinoma. To date, there are few extensive molecular studies on retinoblastoma in Filipino patients. To this end, the study aimed to describe the copy number of CD133, KRT19, and MUC1 in retinoblastoma samples from a Filipino patient and quantitate the respective expression level of these genes.
Methods:
Hematoxylin & Eosin (H&E) staining was utilized to characterize the retinoblastoma tissue while fluorescence in situ hybridization (FISH) using probes specific to CD133, KRT19, and MUC1 was performed to determine the copy number of genes in retinoblastoma samples from a Filipino patient (n = 1). The gene expression of CD133, MUC1, and KRT19 was quantitated using RT-qPCR.
Results:
The H&E staining in the retinoblastoma tissue shows poorly differentiated cells with prominent basophilic nuclei. CD133 was approximately 1.5-fold overexpressed in the retinoblastoma tissue with respect to the normal tissue, while MUC1 and KRT19 are only slightly expressed. Multiple intense signals of each probe were localized in the same nuclear areas throughout the retinoblastoma tissue, with high background noise.
Conclusion
These findings suggest that CD133 is a potential biomarker for the staging and diagnosis of retinoblastoma in Filipino cancer patients. However, further optimization of the hybridization procedures is recommended.
Retinoblastoma
;
Biomarkers
;
In Situ Hybridization